compound semaglutide hims A New Era of Weight Management is Coming to & Hers Hims & Hers Expands Personalized

If you experience symptoms that are concerning to you or do not resolve, please consult your healthcare provider

The STEP clinical trial program demonstrated that semaglutide consistently produced 10.9% to 14.9% weight loss across diverse patient populations, with 83.5% of participants achieving clinically meaningful weight loss of 5% or more

Like other GLP-1 agonists, Retatrutide aids in glycemic control and satiety, or the feeling of fullness

[Online] Chamberlin, S., & Dabbs, W

Side Effects by Medication Understand how different weight loss solutions affect your body, from digestive discomfort to hormonal shifts, and know what to expect before you start